InvestorsHub Logo

XenaLives

03/02/17 2:13 PM

#94049 RE: Rubyred77 #94047

From your link - didn't know this:


Alzheimer's disease In volunteers No development reported (I) Germany PO / Capsule Anavex Life Sciences 16 Jul 2016
Alzheimer's disease Monotherapy No development reported (Preclinical) Germany IV / unspecified Anavex Life Sciences 16 Jul 2016

Investor2014

03/02/17 2:46 PM

#94053 RE: Rubyred77 #94047

An impressive read the way the Anavex accomplishments and events are laid out in that report!

powerwalker

03/02/17 4:01 PM

#94062 RE: Rubyred77 #94047

Ruby, sent your links to the author of the article in the following post from Xena.

attilathehunt

05/31/17 8:10 AM

#106631 RE: Rubyred77 #94047

Perhaps Missling will use the Jeffries conference to announce the plus patent and Jeffries will use that to project price target.